CEO sales are mechanically tied to option exercises (cashless exercise-and-sell pattern) and are immaterial relative to market cap. The Q2 revenue miss and Tyvaso competitive headwinds are the more relevant near-term catalysts. Monitor upcoming ralinepag and Nebulized Tyvaso NDA decisions for pipeline-driven upside.
Price Chart
Executive Summary
CEO Martine Rothblatt sold ~$5.5M in open-market shares on August 10, 2026, following option exercises, while EVP Paul Mahon sold $682K on August 6. The cluster follows a mixed Q2 earnings report (revenue miss, EPS beat) and represents 0.025% of market cap — trivial in proportion. The CEO's sales are likely liquidity-driven after derivative exercises, not a bearish signal.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold 7,500 open-market shares for ~$5.5M on Aug 10, 2026, alongside exercising 19,000 options (9,500 at $0, 9,500 at $135.42)
- EVP Paul Mahon sold 1,300 shares for $682K on Aug 6, 2026
- Total cluster open-market sales: ~$6.2M, representing 0.028% of $22.1B market cap
- Q2 2026 revenue of $783.3M missed $804.6M consensus by 2.7%; EPS of $7.27 beat $6.86 estimate by 5.9%
- Tyvaso sales declined 4% YoY, with Nebulized Tyvaso down 18% YoY
Financial Impact
Open-market sales of ~$6.2M represent 0.028% of $22.1B market cap — trivial and routine
Risk Factors
- Tyvaso franchise facing competitive pressure in inhaled prostacyclin class
- Revenue decline of 2% YoY may signal market share loss
- CEO's consistent option-exercise-and-sell pattern could continue, creating modest overhang
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1786525314104 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $571.38 (+14.20%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $571.38 (+14.94%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $571.38 (+13.40%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $571.38 (+12.74%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $571.38 (+17.18%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $571.38 (+17.05%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $571.38 (+10.85%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $571.38 (+8.23%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access